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                         Key points 
Proteomic and Pathway analysis of  
human   PRKACA (P17612) 
Retrieval of  3D-structure (2GU8) and 
active site  determination  
15 published inhibitors : 
H-89, Roscovitine-1, PP-2, 
Birb796, Mallotoxin, H-89,  
SB-203580, SB 202190,              
HA-  1077,GO-6983, KN-62, 
Flavopiridin,Roscovitine-2 , 
Gleevec and Ligand“796” 
 Figure 1. Activation of human PRKACA via G-protein 
 and cAMP  
Figure 2: Human cAMP dependent PRKACA 
role in cell signaling mechanism 
                    Materials and methods 
        Ligand identification  
   Ligand based virtual screening 
Generation of grid around the active 
site residues of protein 
Filtering of 5388 conformations 
using  LigPrep 
Docking and scoring studies using 
Schrodinger software 
Sequential application of   
HTVS, SP and  XP docking 
Selection of best lead molecules based on the dock score and interacting 
properties with the target protein 
Figure4. Docking of lead‘1’ molecule with 
human PRKACA and hydrogen bonding net-
work with the residues at Thr-51, Glu-121, 
Val-123, Glu-127 and Thr-183, blocking the 
functional activity of the protein. 
Figure3.Three- dimensional structure of 2GU8 
protein 
                  Results and discussion 
Proteomic analysis reveals that the functional properties of human cAMP dependent 
PRKACA. 
Pathway analysis reveals that the role of protein during  signaling  mechanism. 
Ligand based virtual screening was performed, and finally best 20 lead molecules were re-
ported based on the XP Gscore.  
Lead ‘1’ (Leptosidin) with lowest docking score.-11.02 Kcal/mol was reported as a best lead 
molecule to inhibit functional activity of the protein. 
          Conclusion 
Signal transduction mechanisms were very important in the cell survival.  
Lead1 (Leptosidin) molecule  forming  five hydrogen bonds at Thr-51,Glu-121,Val-123,Glu-
127 and Thr-183 which were reported earlier in co-crystallographic structure. 
The twenty lead molecules reported in the present study have good binding affinity towards 
human cAMP dependent PRKACA. However, Leptosidin with lowest XP Gscore and good 
binding orientation with the important active site residues is suggested as best lead for de-
signing potential inhibitor. 
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Asinex Ltd. Subset, AKos GmbH subset, 
KEGG, Drug likeness NCI, Anti HIV NCI 
subset, UN annotated NCI subset, Chem 
PDB ChemBank. (one million entries) 
5388 Ligand analogues were       
generated 
Figure 5. Predicted 20 best lead molecules based on the XP Gscore 
The advancement in therapeutic applications focused on specific macromolecules of deregulated 
cell signaling pathways bestowed novel approach to design the ligands as drug molecules against 
several life threatening diseases such as Cancer.  
Protein kinase A is one of the important protein in the cell signaling mechanism.  cAMP, G-
proteins and ATP molecules were required for activation of protein kinase A (PKA), upon activa-
tion, PKA catalytic subunits (PRKACA, PRKACB and PRKACG) undergoes many cellular func-
tions like cell proliferations, cell cycle regulation, and survival of cells through acting on many 
substrates.  
Over expression of extracellular cAMP dependent protein kinase A catalytic subunits (PRKACA) 
causes severe tumorgenesis in different organs (prostate gland, breast, lungs and pancreas) leading 
to cancer. 
High throughput virtual screening was implemented herein to identify the potent leads for human 
PRKACA that stimulates chronic form of cancers. 
In silico functional and phylogenetic  analysis of the PRKACA protein provided enough evidences 
towards its cancer stimulating nature.  
Fifteen published inhibitors were taken, ligand analogues were prepared. Lead identification, lead 
optimization was performed and finally best lead molecules were reported based on the docking 
scores. 
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